Novel miRNA biomarker and treatment of memory impairment
Age associated dementia consist a serious health and social problem for our society, with their prevalence increasing as lifespan expands. Efficient therapeutic strategies to treat memory decline are still missing. Scientists of the University of Göttingen have now developed a new biomarker and medical approach for treatment of dementia and of other memory impairment conditions. This includes discovery of a new microRNA (miRNA) biomarker associated with learning and memory and its therapeutic manipulation, in particular to rescue learning impairment in dementia.
Further Information: PDF
MBM ScienceBridge GmbH
Phone: (0551) 30724-151
Contact
Dr. Jens-Peter Horst
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Largest magnetic anisotropy of a molecule measured at BESSY II
At the Berlin synchrotron radiation source BESSY II, the largest magnetic anisotropy of a single molecule ever measured experimentally has been determined. The larger this anisotropy is, the better a…
Breaking boundaries: Researchers isolate quantum coherence in classical light systems
LSU quantum researchers uncover hidden quantum behaviors within classical light, which could make quantum technologies robust. Understanding the boundary between classical and quantum physics has long been a central question…
MRI-first strategy for prostate cancer detection proves to be safe
Active monitoring is a sufficiently safe option when prostate MRI findings are negative. There are several strategies for the early detection of prostate cancer. The first step is often a…